211 related articles for article (PubMed ID: 22584956)
1. Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases.
Alvarado G; Noor R; Bassett R; Papadopoulos NE; Kim KB; Hwu WJ; Bedikian A; Patel S; Hwu P; Davies MA
Melanoma Res; 2012 Aug; 22(4):310-5. PubMed ID: 22584956
[TBL] [Abstract][Full Text] [Related]
2. Risk of intracranial hemorrhage associated with therapeutic anticoagulation for venous thromboembolism in cancer patients: a systematic review and meta-analysis.
Rojas-Hernandez CM; Oo TH; García-Perdomo HA
J Thromb Thrombolysis; 2017 Feb; 43(2):233-240. PubMed ID: 27704333
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic anticoagulation for venous thromboembolism after recent brain surgery: Evaluating the risk of intracranial hemorrhage.
de Melo Junior JO; Lodi Campos Melo MA; da Silva Lavradas LA; Ferreira Lopes PG; Luiz Ornelas II; de Barros PL; da Mata Pereira PJ; Niemeyer Filho P
Clin Neurol Neurosurg; 2020 Oct; 197():106202. PubMed ID: 32916398
[TBL] [Abstract][Full Text] [Related]
4. Risk of intracranial bleeding in patients with primary brain cancer receiving therapeutic anticoagulation for venous thromboembolism: A meta-analysis.
Porfidia A; Giordano M; Sturiale CL; D'Arrigo S; Donadini MP; Olivi A; Ageno W; Pola R
Brain Behav; 2020 Jun; 10(6):e01638. PubMed ID: 32314875
[TBL] [Abstract][Full Text] [Related]
5. The balance of risk of bleeding and thrombosis in melanoma patients with brain metastases.
Uchino K
Melanoma Res; 2013 Feb; 23(1):82. PubMed ID: 23196331
[No Abstract] [Full Text] [Related]
6. Intracranial hemorrhage in cancer patients treated with anticoagulation.
Weinstock MJ; Uhlmann EJ; Zwicker JI
Thromb Res; 2016 Apr; 140 Suppl 1():S60-5. PubMed ID: 27067980
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation.
Zwicker JI; Karp Leaf R; Carrier M
J Thromb Haemost; 2016 Sep; 14(9):1736-40. PubMed ID: 27306689
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulation in the Setting of Primary and Metastatic Brain Tumors.
Mantia C; Zwicker JI
Cancer Treat Res; 2019; 179():179-189. PubMed ID: 31317488
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulant Management and Outcomes in Nontraumatic Intracranial Hemorrhage Complicated by Venous Thromboembolism: A Retrospective Chart Review.
Gorman J; Candeloro M; Schulman S
Thromb Haemost; 2023 Oct; 123(10):966-975. PubMed ID: 37015326
[TBL] [Abstract][Full Text] [Related]
10. Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin.
Mantia C; Uhlmann EJ; Puligandla M; Weber GM; Neuberg D; Zwicker JI
Blood; 2017 Jun; 129(25):3379-3385. PubMed ID: 28468796
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulation for the treatment of venous thromboembolism in patients with brain metastases: a meta-analysis and systematic review.
Hunter BD; Minichiello T; Bent S
J Thromb Thrombolysis; 2017 Oct; 44(3):392-398. PubMed ID: 28836150
[TBL] [Abstract][Full Text] [Related]
12. Venous Thrombotic Events and Anticoagulation in Brain Tumor Patients.
Diaz M; Jo J
Curr Oncol Rep; 2022 Apr; 24(4):493-500. PubMed ID: 35179708
[TBL] [Abstract][Full Text] [Related]
13. Safety of long-term anticoagulation in patients with brain metastases.
Horstman H; Gruhl J; Smith L; Ganti AK; Shonka NA
Med Oncol; 2018 Mar; 35(4):43. PubMed ID: 29497873
[TBL] [Abstract][Full Text] [Related]
14. Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study.
Donato J; Campigotto F; Uhlmann EJ; Coletti E; Neuberg D; Weber GM; Zwicker JI
Blood; 2015 Jul; 126(4):494-9. PubMed ID: 25987658
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of low-molecular-weight heparin treatment for venous thromboembolism in patients with primary and metastatic brain tumours.
Chai-Adisaksopha C; Linkins LA; ALKindi SY; Cheah M; Crowther MA; Iorio A
Thromb Haemost; 2017 Feb; 117(3):589-594. PubMed ID: 28078351
[TBL] [Abstract][Full Text] [Related]
16. Between Scylla and Charybdis: risks of early therapeutic anticoagulation for venous thromboembolism after acute intracranial hemorrhage.
Nguyen T; Sharma M; Crooks P; Patel PV; Bonow RH; Creutzfeldt CJ; Wahlster S
Br J Neurosurg; 2022 Apr; 36(2):251-257. PubMed ID: 35343356
[TBL] [Abstract][Full Text] [Related]
17. Risk of Venous Thromboembolism After Receiving Prothrombin Complex Concentrate for Warfarin-associated Intracranial Hemorrhage.
Felton D; Foley EM; Traub SJ; Vodonos A; Ganetsky M
J Emerg Med; 2016 Jan; 50(1):1-6. PubMed ID: 26409668
[TBL] [Abstract][Full Text] [Related]
18. Balancing bleeding in brain metastases.
Kreuziger LB
Blood; 2015 Jul; 126(4):432-3. PubMed ID: 26206944
[TBL] [Abstract][Full Text] [Related]
19. Management of venous thromboembolism in high-grade glioma: Does low molecular weight heparin increase intracranial bleeding risk?
Jo J; Donahue J; Sarai G; Petroni G; Schiff D
Neuro Oncol; 2022 Mar; 24(3):455-464. PubMed ID: 34383073
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Anticoagulation in Patients with Primary Brain Tumors or Secondary Brain Metastasis.
Lin RJ; Green DL; Shah GL
Oncologist; 2018 Apr; 23(4):468-473. PubMed ID: 29158366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
